We established
SIX2-GFP iPSCs by transfecting the targeting vector, along with the TALEN expression plasmids (Sakuma et al., 2013 (
link)), into human iPSCs (201B7) (Takahashi et al., 2007 (
link)). A full description of the methods is provided in
Supplemental Experimental Procedures. We obtained 23 heterozygous GFP-knockin clones among 91 clones, as determined by PCR, Southern blotting, and sequencing of the non-GFP-containing allele. Clone #12 was adapted to the feeder-free condition using
StemFit AK02N medium (Takara Bio, AJ100) and plates coated with
iMatrix-511 silk (Nippi, #892021), as described previously (Nakagawa et al., 2014 (
link), Yoshimura et al., 2017 (
link)), and further electroporated with a plasmid expressing Cre recombinase to delete the puromycin-resistant cassette. The resultant colonies were picked up in duplicate and puromycin-sensitive clones were expanded. The absence of the cassette was verified by PCR, and clones #12-8 and #12-12 were used for detailed analyses. We used clone #12-12 for most of the presented data, but consistent data were obtained for clone #12-8 (see
Figure S3).
Tanigawa S., Naganuma H., Kaku Y., Era T., Sakuma T., Yamamoto T., Taguchi A, & Nishinakamura R. (2019). Activin Is Superior to BMP7 for Efficient Maintenance of Human iPSC-Derived Nephron Progenitors. Stem Cell Reports, 13(2), 322-337.